Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Not enough interest on the B.B. for Sirona

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon May 06, 2023 2:56am

172 Views

Post# 35434357

RE:Not enough interest on the B.B. for Sirona

My impression is that the number of views of the bullboard postings has declined, more or less cut in half.

In a way, this reflects investors interest of the company. Management is responsible to turn the tide - let's get started!

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023